Effects of the PPARγ agonist GW1929 on muscle wasting in tumour-bearing mice

被引：1

作者：

Moore-Carrasco, Rodrigo ^{[1
,2
]}

Figueras, Maite ^{[1
]}

Ametller, Elisabet ^{[1
]}

Lopez-Soriano, Francisco J. ^{[1
]}

Argiles, Josep M. ^{[1
]}

Busquets, Silvia ^{[1
]}

机构：

[1] Univ Barcelona, Fac Biol, Canc Res Grp, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain

[2] Univ Talca, Dept Bioquim Clin & Inmunohematol, Talca, Chile

来源：

ONCOLOGY REPORTS | 2008年 / 19卷 / 01期

关键词：

PPAR gamma; muscle wasting; cancer; MyoD; glucose transport; GLUT-4;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Administration of the PPAR gamma agonist GW1929 (10 mg/kg body weight) results in amelioration of muscle loss in tumour-bearing mice experimental cachexia. The effect of the agonist, which seems to be specific for white muscle extensor digitorum longus (EDL), is accompanied by an increase in the levels of the transcription factor MyoD and also the GLUT-4 glucose transporter. In addition, the effects of GW1929 on skeletal muscle are direct since incubation of isolated rat skeletal muscles in its presence results in a decreased rate of protein degradation. Collectively, the results presented suggest a potential clinical application - possibly in combination with other anabolic strategies - of GW1929 in restoring muscle waste during cancer cachexia.

引用

页码：253 / 256

页数：4

共 50 条

[21] Synergistic Effects of Irinotecan and Flavonoids on Ehrlich Ascites Tumour-Bearing Mice
Knezevic, Anica Horvat
Dikic, Domagoj
Lisicic, Duje
Kopjar, Nevenka
Orsolic, Nada
Karabeg, Sanja
Benkovic, Vesna
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (05) : 343 - 349
[22] Effects of GW1929 on uterus, ovary and bone metabolism function in perimenopause rats
Wang, Xiaoli
Xu, Kehui
Xiong, Ying
Li, Qiao
Zhao, Xia
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 1884 - 1893
[23] GW1929: A nonthiazolidinedione PPARγ agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation
Kaundal, Ravinder K.
Sharma, Shyam Sunder
BEHAVIOURAL BRAIN RESEARCH, 2011, 216 (02) : 606 - 612
[24] BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing rats
Irminger-Finger, Irmgard
Busquets, Silvia
Calabrio, Fabrice
Lopez-Soriano, Francisco J.
Argiles, Josep M.
ONCOLOGY REPORTS, 2006, 15 (06) : 1425 - 1428
[25] Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats
Figueras, M
Busquets, S
Carbó, N
Barreiro, E
Almendro, V
Argilés, JM
López-Soriano, FJ
FEBS LETTERS, 2004, 569 (1-3): : 201 - 206
[26] PPARgamma agonist GW1929 inhibits proliferation, induces apoptosis, and decreases invasiveness of prostate cancer cells
Kishkareva, Yekaterina A.
Monroy, M. Alexandra
Engdahl, Ryan
Frasson, Matteo
Yerrum, Smitha
Daly, John
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (03) : S103 - S103
[27] THE FREQUENCY OF MITOSIS IN THE EPIDERMIS OF NORMAL AND TUMOUR-BEARING MICE
LAWS, JO
WRIGHT, GP
BRITISH JOURNAL OF CANCER, 1952, 6 (03) : 236 - 241
[28] The immune influence of a parabiosis model on tumour-bearing mice
Feng Nan
Luo Jianmin
Guo Ximin
SWISS MEDICAL WEEKLY, 2018, 148
[29] PROTECTIVE EFFECTS OF POLL GLAND SECRETION ON IMMUNOSUPPRESSED AND 5180 TUMOUR-BEARING MICE
Hasi, Surong
Tumen, Bayaer
JOURNAL OF CAMEL PRACTICE AND RESEARCH, 2017, 24 (01) : 41 - 48
[30] Apoptosis study in thymic involution in tumour-bearing mice
Valdez, JC
Rachid, M
Gobbato, N
Perdigon, G
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1998, 11 (02) : 49 - 55

← 1 2 3 4 5 →